Posting your personal information on Facebook, Twitter, Instagram, or TikTok puts you at risk for identity theft, says the BBB. Wanna tell the world that you got the COVID-19 vaccine ? Great. Posting it on social media? Go, you! Including a photo to get more likes? No problem. Snapping a pic of your vaccination card? Stop! Read Full Story

The director general of the World Health Organization is confident that the coronavirus vaccine will be available by the end of 2020.

Despite Facebook’s countermeasures, the photo-sharing app remains a nexus for content that sows doubt in the COVID-19 vaccines. This story is part of Doubting the Dose, a series that examines anti-vaccine sentiment and the role of misinformation in supercharging it. Read more here . Read Full Story

When and how you’ll be notified about your place in the vaccine line—and how proactive you’ll have to be in finding the information—will depend heavily on the state and city you live in. The Onion recently satirized the disjointed nature of information around the vaccine rollout, suggesting that the best shot at staying informed is to cobble together information from Twitter accounts of “reporters, medical researchers, and politically engaged musicians… [and a] Tacoma-area mom who shares screenshots of vital information.” Read Full Story

The clinic will be open to all Washingtonians who qualify for immunization.

This is the comparison of the COVID-19 vaccines that are considered for their next application in Latin America.

A shot is coming to your arm soon. Now that multiple vaccines are rushing toward production, it’s psychologically safe to see a light at the end of the COVID-19 tunnel, and ask some questions about when and how a vaccine might come your way. Here, we’ll try to answer a few vaccine-related questions you may be having: Read Full Story

If you were hoping that the new COVID-19 vaccines could make it possible to stop wearing masks and social distancing, think again. Pfizer’s new COVID-19 vaccine might get FDA emergency use authorization in a few weeks, and a small group of Americans might begin getting shots in December. Moderna’s vaccine might quickly follow. But even for those who can get vaccinated soon—potentially 20 million people in the U.S., out of a population of more than 320 million—life won’t be able to go back to normal yet. Read Full Story

“People tend to think that on the first of January or the first of April, I’m going to get the vaccine, and then things will be back to normal. It’s not going to work like that.” As there are fewer than three months left to the year, and as another COVID-19 vaccination trial has been forced to hit the pause button , it’s looking increasingly unlikely that there will be a COVID-19 vaccine this year. Read Full Story

JPMorgan has downgraded shares in COVID-19 vaccine maker Moderna’s stock over valuation concerns. The drop is from overweight to neutral. JPMorgan has downgraded shares in COVID-19 vaccine maker Moderna’s stock over valuation concerns. Read Full Story